D141003
2-(Dimethylamino)ethanethiol hydrochloride
95%
Synonym(s):
MEDA
Sign Into View Organizational & Contract Pricing
All Photos(3)
About This Item
Linear Formula:
(CH3)2NCH2CH2SH · HCl
CAS Number:
Molecular Weight:
141.66
Beilstein/REAXYS Number:
3906670
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22
Recommended Products
Quality Level
assay
95%
form
solid
mp
150-160 °C (lit.)
SMILES string
Cl.CN(C)CCS
InChI
1S/C4H11NS.ClH/c1-5(2)3-4-6;/h6H,3-4H2,1-2H3;1H
InChI key
NRVFDGZJTPCULU-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Application
2-(Dimethylamino)ethanethiol hydrochloride can be used:
- To synthesize fluorescent thiocholine esters containing dansyl group in the acyl portions, which are potent substrates for the human fibrinoligase.
- As a cationic ligand for the surface modification of gold nanoparticles.
- For the modification of cellulose 10-undecenoyl ester (CUE) to form organo-soluble ionic cellulose derivatives.
Metal-complexing agent
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
New thioester substrates for fibrinoligase (coagulation factor XIIIa) and for transglutaminase. Transfer of the fluorescently labeled acyl group to amines and alcohols
Parameswaran KN
BioChemistry: An Indian Journal, 20(13), 3703-3711 (1981)
Ahmed Bassiouni et al.
Frontiers in cellular and infection microbiology, 10, 137-137 (2020-04-24)
This study offers a novel description of the sinonasal microbiome, through an unsupervised machine learning approach combining dimensionality reduction and clustering. We apply our method to the International Sinonasal Microbiome Study (ISMS) dataset of 410 sinus swab samples. We propose
The prevalence of comorbidities in COPD patients, and their impact on health status and COPD symptoms in primary care patients: a protocol for an UNLOCK study from the IPCRG.
Björn Ställberg et al.
NPJ primary care respiratory medicine, 26, 16069-16069 (2016-11-18)
Annice Heratizadeh et al.
The Journal of allergy and clinical immunology, 140(3), 845-853 (2017-03-01)
Atopic dermatitis (AD) is a chronic relapsing skin disease prevalent in 1% to 3% of adults in Western industrialized countries. We sought to investigate the effectiveness of educational training in an outpatient setting on coping with the disease, quality of
Désirée E S Larenas-Linnemann et al.
Current allergy and asthma reports, 18(5), 33-33 (2018-05-11)
Since omalizumab has been approved for urticaria, numerous randomized and real-life observational trials have been published. We reviewed the period January 2017-February 2018. Omalizumab is effective for the control of urticaria recalcitrant to antihistamines in different populations globally. The ratio
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service